Dades de l’estudi. Dipòsit de dades al Centre de Medicina de l’Esport- Unitat d’Esport i Salut. Consell Català de l’Esport. Esplugues de Llobregat.(Spain)
Enllaç:
https://www.apunts.org/en-the-use-face-masks-impact-articulo-S2666506923000159
Name | day | mask | age | gender |
Subject 1 | 03/02/2020 | no | 20 | h |
Subject 2 | 03/02/2020 | no | 23 | h |
Subject 3 | 04/11/2019 | no | 15 | h |
Subject 4 | 18/06/2019 | no | 15 | d |
Subject 5 | 15/10/2019 | no | 17 | d |
Subject 6 | 17/10/2019 | no | 16 | d |
Subject 7 | 02/10/2020 | no | 14 | h |
Subject 8 | 02/07/2019 | no | 18 | h |
Subject 9 | 14/10/2019 | no | 16 | d |
Subject 10 | 09/10/2019 | no | 15 | d |
Subject 11 | 28/10/2019 | no | 14 | h |
Subject 12 | 22/10/2020 | no | 16 | d |
Subject 13 | 04/11/2021 | no | 15 | h |
Subject 14 | 02/07/2019 | no | 17 | h |
Subject 15 | 22/10/2019 | no | 15 | d |
Subject 16 | 06/06/2019 | no | 15 | d |
Subject 17 | 10/02/2020 | no | 16 | d |
Subject 18 | 06/11/2019 | no | 16 | h |
Subject 19 | 08/10/2019 | no | 16 | d |
Subject 20 | 28/10/2019 | no | 15 | d |
Subject 21 | 09/10/2009 | no | 15 | d |
Subject 22 | 09/10/2019 | no | 15 | d |
Subject 23 | 04/12/2018 | no | 18 | h |
Subject 24 | 02/10/2019 | no | 15 | h |
Subject 25 | 03/10/2019 | no | 15 | h |
Subject 26 | 04/02/2019 | no | 21 | h |
Subject 27 | 08/10/2019 | no | 19 | d |
Subject 28 | 03/10/2019 | No | 15 | h |
Subject 29 | 03/02/2020 | no | 18 | h |
Average | 16,4 | |||
SD | 2,1 | |||
Name | day | mask | age | gender |
subject 1 | 22/02/2021 | yes | 21 | h |
subject 2 | 22/02/2021 | yes | 24 | h |
subject 3 | 03/02/2021 | yes | 15 | h |
subject 4 | 03/11/2020 | yes | 16 | d |
subject 5 | 09/11/2020 | yes | 18 | d |
subject 6 | 10/11/2020 | yes | 17 | d |
subject 7 | 15/12/2020 | yes | 15 | h |
subject 8 | 25/11/2020 | yes | 18 | h |
subject 9 | 11/11/2020 | yes | 17 | d |
subject 10 | 09/11/2020 | yes | 16 | d |
subject 11 | 05/02/2021 | yes | 15 | h |
subject 12 | 11/11/2020 | yes | 17 | d |
subject 13 | 19/11/2021 | yes | 16 | h |
subject 14 | 25/11/2020 | yes | 17 | h |
subject 15 | 09/02/2021 | yes | 16 | d |
subject 16 | 02/11/2020 | yes | 16 | d |
subject 17 | 01/02/2021 | yes | 16 | d |
subject 18 | 03/02/2021 | yes | 16 | h |
subject 19 | 23/10/2020 | yes | 17 | d |
subject 20 | 29/10/2019 | yes | 15 | d |
subject 21 | 10/11/2020 | yes | 16 | d |
subject 22 | 02/11/2020 | yes | 16 | d |
subject 23 | 08/02/2021 | yes | 20 | h |
subject 24 | 17/12/2020 | yes | 15 | h |
subject 25 | 16/12/2020 | yes | 15 | h |
subject 26 | 22/10/2021 | yes | 22 | h |
subject 27 | 09/02/2021 | yes | 21 | d |
subject 28 | 19/01/2021 | yes | 15 | h |
subject 29 | 22/02/2021 | yes | 19 | h |
Average | 17,1 | |||
SD | 2,4 |
Name | Average HR | SD HR | SD ms | Average ms |
Subject 1 | 64,6 | 3,1 | 43,7 | 931,2 |
Subject 2 | 60,8 | 4,7 | 80,6 | 991,6 |
Subject 3 | 59,1 | 0,9 | 15,7 | 1016,0 |
Subject 4 | 60,1 | 6,3 | 99,5 | 1007,1 |
Subject 5 | 59,3 | 4,2 | 67,1 | 1015,6 |
Subject 6 | 57,3 | 5,5 | 91,9 | 1054,2 |
Subject 7 | 68,2 | 6,0 | 74,5 | 886,2 |
Subject 8 | 63,9 | 4,5 | 70,6 | 943,6 |
Subject 9 | 39,9 | 0,7 | 28,3 | 1504,7 |
Subject 10 | 75,1 | 3,5 | 36,9 | 800,0 |
Subject 11 | 52,5 | 2,6 | 59,3 | 1145,0 |
Subject 12 | 59,1 | 8,7 | 172,3 | 1037,3 |
Subject 13 | 65,7 | 5,4 | 74,3 | 918,8 |
Subject 14 | 62,5 | 1,8 | 25,9 | 964,0 |
Subject 15 | 65,8 | 2,7 | 37,1 | 913,6 |
Subject 16 | 53,9 | 3,2 | 66,3 | 1115,6 |
Subject 17 | 82,8 | 2,2 | 20,9 | 725,2 |
Subject 18 | 60,8 | 1,7 | 26,7 | 988,0 |
Subject 19 | 61,1 | 7,0 | 99,7 | 1012,5 |
Subject 20 | 94,5 | 2,3 | 15,5 | 635,1 |
Subject 21 | 55,9 | 7,5 | 137,2 | 1088,9 |
Subject 22 | 59,6 | 2,3 | 39,7 | 1007,6 |
Subject 23 | 69,2 | 8,6 | 107,2 | 878,9 |
Subject 24 | 50,1 | 0,4 | 8,8 | 1197,0 |
Subject 25 | 60,8 | 7,9 | 129,1 | 1002,2 |
Subject 26 | 54,4 | 0,7 | 14,3 | 1103,0 |
Subject 27 | 54,2 | 6,0 | 133,3 | 1119,0 |
Subject 28 | 75,0 | 10,2 | 103,2 | 812,4 |
Subject 29 | 52,7 | 1,5 | 32,7 | 1140,0 |
Average: | 62,0 | 4,2 | 65,9 | 998,4 |
SD: | 10,4 | 2,7 | 43,5 | 160,4 |
Name | Average HR | SD HR | SD ms | Average ms |
subject 1 | 57,1 | 2,2 | 39,4 | 1052,4 |
subject 2 | 45,6 | 1,9 | 54,8 | 1318,3 |
subject 3 | 64,5 | 0,7 | 9,7 | 930,4 |
subject 4 | 56,9 | 7,7 | 155,4 | 1072,5 |
subject 5 | 70,0 | 7,7 | 111,3 | 868,7 |
subject 6 | 67,9 | 6,1 | 78,3 | 890,0 |
subject 7 | 58,9 | 2,0 | 35,9 | 1019,6 |
subject 8 | 60,1 | 7,0 | 115,0 | 1009,3 |
subject 9 | 49,0 | 9,4 | 212,6 | 1258,3 |
subject 10 | 63,6 | 7,5 | 120,3 | 955,6 |
subject 11 | 49,0 | 2,6 | 65,8 | 1227,5 |
subject 12 | 63,1 | 5,2 | 81,9 | 957,2 |
subject 13 | 65,3 | 5,4 | 80,5 | 925,0 |
subject 14 | 44,7 | 3,4 | 93,7 | 1347,4 |
subject 15 | 73,6 | 7,0 | 74,4 | 821,8 |
subject 16 | 57,0 | 6,2 | 117,5 | 1064,0 |
subject 17 | 69,0 | 6,0 | 79,2 | 873,2 |
subject 18 | 59,1 | 4,2 | 69,8 | 1020,0 |
subject 19 | 63,3 | 7,8 | 133,8 | 971,0 |
subject 20 | 60,5 | 2,2 | 36,1 | 993,3 |
subject 21 | 57,4 | 10,4 | 163,8 | 1071,1 |
subject 22 | 61,1 | 4,5 | 74,4 | 987,6 |
subject 23 | 55,0 | 3,8 | 73,8 | 1096,0 |
subject 24 | 50,6 | 2,1 | 47,4 | 1186,5 |
subject 25 | 59,6 | 8,6 | 135,3 | 1023,6 |
subject 26 | 51,7 | 0,5 | 10,2 | 1161,0 |
subject 27 | 58,1 | 5,1 | 85,4 | 1039,1 |
subject 28 | 72,6 | 10,1 | 118,6 | 841,8 |
subject 29 | 53,8 | 1,3 | 26,4 | 1115,0 |
Average: | 59,2 | 5,1 | 86,2 | 1037,8 |
SD: | 7,5 | 2,9 | 47,2 | 136,2 |
T test: | 0,134 | 0,094 | 0,036 | 0,167 |
Resultats Variabilitat Cardiaca. (HRV):
Name | mask | RMSSD | NN50 | number arrhythmic beats | PNN50 |
Subject 1 | no | 41,1 | 3 | 8 | 37,5 |
Subject 2 | no | 67,9 | 3 | 9 | 33,3 |
Subject 3 | no | 26,0 | 1 | 8 | 12,5 |
Subject 4 | no | 122,2 | 5 | 8 | 62,5 |
Subject 5 | no | 96,5 | 4 | 6 | 66,7 |
Subject 6 | no | 70,5 | 3 | 8 | 37,5 |
Subject 7 | no | 67,3 | 7 | 9 | 77,8 |
Subject 8 | no | 59,9 | 2 | 8 | 25,0 |
Subject 9 | no | 33,8 | 1 | 5 | 20,0 |
Subject 10 | no | 39,0 | 2 | 10 | 20,0 |
Subject 11 | no | 58,6 | 4 | 7 | 57,1 |
Subject 12 | no | 185,4 | 6 | 8 | 75,0 |
Subject 13 | no | 66,2 | 3 | 9 | 33,3 |
Subject 14 | no | 36,5 | 1 | 8 | 12,5 |
Subject 15 | no | 31,5 | 0 | 9 | 0,0 |
Subject 16 | no | 86,5 | 4 | 7 | 57,1 |
Subject 17 | no | 20,4 | 0 | 9 | 0,0 |
Subject 18 | no | 33,5 | 0 | 8 | 0,0 |
Subject 19 | no | 179,4 | 4 | 7 | 57,1 |
Subject 20 | no | 17,7 | 0 | 8 | 0,0 |
Subject 21 | no | 170,1 | 7 | 8 | 87,5 |
Subject 22 | no | 57,4 | 5 | 9 | 55,6 |
Subject 23 | no | 107,8 | 5 | 10 | 50,0 |
Subject 24 | no | 12,4 | 0 | 7 | 0,0 |
Subject 25 | no | 214,0 | 8 | 9 | 88,9 |
Subject 26 | no | 19,1 | 0 | 7 | 0,0 |
Subject 27 | no | 84,3 | 5 | 7 | 71,4 |
Subject 28 | No | 61,1 | 5 | 10 | 50,0 |
Subject 29 | no | 49,0 | 1 | 6 | 16,7 |
Average | 72,9 | 3,1 | 8,0 | 38,1 | |
SD | 54,2 | 2,4 | 1,2 | 29,0 | |
Name | mask | RMSSD | NN50 | number arrhythmic beats | PNN50 |
subject 1 | yes | 55,2 | 5 | 8 | 63 |
subject 2 | yes | 96,3 | 5 | 6 | 83 |
subject 3 | yes | 8,8 | 0 | 8 | 0 |
subject 4 | yes | 245,8 | 6 | 7 | 86 |
subject 5 | yes | 189,1 | 3 | 6 | 50 |
subject 6 | yes | 59,9 | 4 | 9 | 44 |
subject 7 | yes | 50,7 | 2 | 8 | 25 |
subject 8 | yes | 81,8 | 4 | 8 | 50 |
subject 9 | yes | 223,8 | 3 | 6 | 50 |
subject 10 | yes | 118,3 | 6 | 8 | 75 |
subject 11 | yes | 73,8 | 5 | 7 | 71 |
subject 12 | yes | 111,1 | 6 | 9 | 67 |
subject 13 | yes | 78,5 | 4 | 9 | 44 |
subject 14 | yes | 157,8 | 5 | 6 | 83 |
subject 15 | yes | 58,8 | 4 | 10 | 40 |
subject 16 | yes | 174,6 | 7 | 8 | 88 |
subject 17 | yes | 72,6 | 4 | 9 | 44 |
subject 18 | yes | 47,4 | 2 | 8 | 25 |
subject 19 | yes | 179,6 | 6 | 7 | 86 |
subject 20 | yes | 53,9 | 1 | 8 | 13 |
subject 21 | yes | 195,6 | 5 | 8 | 63 |
subject 22 | yes | 76,0 | 6 | 8 | 75 |
subject 23 | yes | 86,3 | 3 | 8 | 38 |
subject 24 | yes | 33,4 | 0 | 7 | 0 |
subject 25 | yes | 444,3 | 7 | 8 | 88 |
subject 26 | yes | 12,7 | 0 | 7 | 0 |
subject 27 | yes | 121,9 | 5 | 8 | 63 |
subject 28 | yes | 132,9 | 7 | 10 | 70 |
subject 29 | yes | 37,6 | 1 | 7 | 14 |
Average | 108,5 | 116,0 | 7,8 | 51,6 | |
SD | 90,0 | 2,1 | 1,2 | 28,1 | |
P< | 0,002 | 0,021 | 0,297 | 0,010 |
Històries clíniques número: Disponibles a la secretaria de la Unitat d’Esport i Salut. Consell Català de l’Esport. Govern de Catalunya.
Us ha agradat aquest article? Compartiu-lo!